Acute posterior leukoencephalopathy in a patient with nephrotic syndrome

Clinical and Experimental Nephrology

Volumn 7, Issue 1, 2003, Pages 63-66

  Utsumi, Kouichi ^a,b   Amemiya, Shimon ^a,b   Iizuka, Miho ^a   Iino, Yasuhiko ^a   Katayama, Yasuo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Hakujikai Memorial Hospital   (Japan)

Author keywords

Cyclosporine; Neurotoxicity; Prednisolone; Reversible posterior leukoencephalopathy syndrome

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYCLOSPORIN; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOENCEPHALOPATHY; NEPHROTIC SYNDROME; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING;

BRAIN DISEASES; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; METHYLPREDNISOLONE; MIDDLE AGED; NEPHROTIC SYNDROME; OCCIPITAL LOBE; PARIETAL LOBE; PREDNISOLONE; PROTEINURIA; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037365745     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101570300009     Document Type: Article

References (17)

1. Hinghey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
2. Gijtenbeek JMM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999;246:339-46.
3. Ghalie R, Fitzsimmons WE, Bennet D, Kaizer H. Cortical blindness: a rare complication of cyclosporine therapy. Bone Marrow Transplant 1990;6:147-8.
4. Hughes RL. Cyclosporine-related central nervous system toxicity in cardiac transplantation. N Engl J Med 1991;323:420-1.
5. Schwartz RB, Bravo SM, Klufas RA, Hsu L, Barnes PD, Robson CD, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165:627-31.
6. Shimizu C, Kimura S, Yoshida Y, Nezu A, Saitoh K, Osaka H, et al. Acute leucoencephalopathy during cyclosporin A therapy in a patient with nephrotic syndrome. Pediatr Nephrol 1994;8:483-5.
7. Meyrier A, Simon P, Perret G, Condamin-Meyrier MC. Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A. BMJ 1986;292:789-92.
8. Niaudet P, Broyer M, Habib R. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. Clin Nephrol (Suppl) 1991;35:31-6.
9. Waldo FB, Kohaut EC. Therapy of focal-segmental glomerulosclerosis with cyclosporin A. Pediatr Nephrol 1987;1:180-2.
10. Kahan BD. Cyclosporine. N Engl J Med 1989;321:1725-38.
11. Patchell RA. Neurological complications of organ transplantation. Ann Neurol 1994;36:688-703.
12. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993;341:1447-51.
13. Humphreys TR, Leyden JJ. Acute reversible central nervous system toxicity associated with low-dose oral cyclosporine therapy. J Am Acad Dermatol 1993;29:490-2.
14. Truwit CL, Denaro CP, Lake JR, DeMarco T. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651-9.
15. Pace MT, Slovis TL, Kelly JK, Abella SD. Cyclosporin A toxicity: MRI appearance of the brain. Pediatr Radiol 1995;25:180-3.
16. Jarosz JM, Howlett DC, Cox TCS, Bingham JB. Cyclosporine-related reversible posterior leukoencephalopathy: MRI. Neuroradiology 1997;39:711-15.
17. Antunes NL, Small TN, George D, Boulad F, Lis E. Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 1999;20:241-3.